期刊
SCIENCE SIGNALING
卷 8, 期 372, 页码 -出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scisignal.aaa0441
关键词
-
资金
- Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG-10312]
- U.K. MRC
- U.K. Medical Research Council
- DSTT (AstraZeneca)
- DSTT (Boehringer-Ingelheim)
- DSTT (GlaxoSmithKline)
- DSTT (Merck-Serono)
- DSTT (Pfizer)
- DSTT (Johnson Johnson)
- MRC [MC_UU_12016/3, MC_U127092717] Funding Source: UKRI
- Medical Research Council [MC_UU_12016/3, MC_U127092717] Funding Source: researchfish
The deubiquitylating enzyme OTUB1 is present in all tissues and targets many substrates, in both the cytosol and nucleus. We found that casein kinase 2 (CK2) phosphorylated OTUB1 at Ser(16) to promote its nuclear accumulation in cells. Pharmacological inhibition or genetic ablation of CK2 blocked the phosphorylation of OTUB1 at Ser(16), causing its nuclear exclusion in various cell types. Whereas we detected unphosphorylated OTUB1 mainly in the cytosol, we detected Ser(16)-phosphorylated OTUB1 only in the nucleus. In vitro, Ser(16)-phosphorylated OTUB1 and nonphosphorylated OTUB1 exhibited similar catalytic activity, bound K63-linked ubiquitin chains, and interacted with the E2 enzyme UBE2N. CK2-mediated phosphorylation and subsequent nuclear localization of OTUB1 promoted the formation of 53BP1 (p53-binding protein 1) DNA repair foci in the nucleus of osteosarcoma cells exposed to ionizing radiation. Our findings indicate that the activity of CK2 is necessary for the nuclear translocation and subsequent function of OTUB1 in DNA damage repair.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据